New structure to strengthen growth
The Gambro Group will develop into three independent companies. Gambro Renal Products will become the new Gambro. Gambro Healthcare and Gambro BCT will gradually become independent companies with formal Boards of Directors and independent governance processes. When the legal reorganization is completed Indap AB will serve as the holding entity of the three new companies. Peter Sjöstrand is elected new Chairman of Gambro AB. Thomas Glanzmann becomes the new CEO of Gambro AB, effective December 1, 2006.
The objective of the new structure is higher efficiency and increased transparency in order to strengthen competitiveness and promote growth. According to the company, the three business areas are today in different stages of development and facing varying challenges and opportunities. By becoming stand-alone companies with three strong Boards of Directors the focus and speed of execution will increase and the companies will be in a better position to serve its customers through increased focus and stronger emphasis on innovation.
Peter Sjöstrand is elected new chairman of Gambro AB. Thomas Glanzmann becomes the new CEO of Gambro AB. He will join Gambro on a full time basis on December 1, 2006, but will gradually be introduced to the organization during November. Following these changes Massimo Rossi resigns as Chairman of the Board of Gambro AB and will become Chairman of the holding company Indap AB and Jan Bruneheim resigns as the CEO of Gambro AB and will become the CEO of Indap AB.
Other news from the department business & finance
